New tool is major milestone against lethal condition, TAU researchers say
Antimicrobial resistance is one of the biggest threats to global health, affecting anyone, at any age, in any country, according to the World Health Organization. Currently, 700,000 deaths each year are attributed to antimicrobial resistance, a figure which could increase to 10 million a year by 2050 save further intervention.
New breakthrough technology from Tel Aviv University facilitates DNA delivery into drug-resistant bacterial pathogens, enabling their manipulation. The research expands the range of bacteriophages, which are the primary tool for introducing DNA into pathogenic bacteria to neutralize their lethal activity. A single type of bacteriophage can be adapted to a wide range of bacteria, an innovation which will likely accelerate the development of potential drugs based on this principle.
Prof. Udi Qimron of the Department of Clinical Microbiology and Immunology at TAU’s Sackler Faculty of Medicine led the research team, which also included Dr. Ido Yosef, Dr. Moran Goren, Rea Globus and Shahar Molshanski, all of Prof. Qimron’s lab. The study was recently published in Molecular Cell and featured on its cover.
For the research, the team genetically engineered bacteriophages to contain the desired DNA rather than their own genome. They also designed combinations of nanoparticles from different bacteriophages, resulting in hybrids that are able to recognize new bacteria, including pathogenic bacteria. The researchers further used directed evolution to select hybrid particles able to transfer DNA with optimal efficiency.
“DNA manipulation of pathogens includes sensitization to antibiotics, killing of pathogens, disabling pathogens’ virulence factors and more,” Prof. Qimron said. “We’ve developed a technology that significantly expands DNA delivery into bacterial pathogens. This may indeed be a milestone, because it opens up many opportunities for DNA manipulations of bacteria that were impossible to accomplish before.
“This could pave the way to changing the human microbiome — the combined genetic material of the microorganisms in humans — by replacing virulent bacteria with a-virulent bacteria and replacing antibiotic-resistant bacteria with antibiotic-sensitive bacteria, as well as changing environmental pathogens,” Prof. Qimron continued.
“We have applied for a patent on this technology and are developing products that would use this technology to deliver DNA into bacterial pathogens, rendering them a-virulent and sensitive to antibiotics,” Prof. Qimron said.
The Latest on: Antimicrobial resistance
- Antimicrobial Susceptibility Test Market is Estimated to Progress at a CAGR of 4.9% during the Forecast Period, observes TMR Studyon August 1, 2022 at 5:30 am
Increase in government expenditure is likely to propel the global market for antimicrobial susceptibility test during the forecast periodWilmington, Delaware, United States, Aug. 01, 2022 (GLOBE ...
- Feeding Dogs Raw Meat Might Exacerbate The Antibiotic Resistance Crisison July 31, 2022 at 1:56 pm
In a new study published in the Journal of Antimicrobial Chemotherapy, a team of researchers at the University of Bristol observed that pet dogs who were predominantly on a diet of raw meat were far ...
- Pandemic-Related Antimicrobial Resistance; A Less Expensive Accrediting Option; First HIV+ to HIV+ Heart Transplanton July 29, 2022 at 2:16 am
CDC saw a significant increase in antimicrobial use and difficulty in following infection prevention and control guidance, resulting in an increase of antimicrobial-resistant healthcare-associated ...
- New breakthrough shows antimicrobial resistance is more evolved than previously recognizedon July 28, 2022 at 9:27 pm
Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.
- CDC: COVID-19 Pandemic Undid Years of Progress in Fight Against Antimicrobial Resistanceon July 28, 2022 at 5:08 am
The COVID-19 pandemic erased years of progress in combating antibacterial resistance in the United States, according to a special report from the US Centers for Disease Control and Prevention (CDC).
- From COVID-19 to antibiotic resistance, we need to tap nature to find new drugson July 27, 2022 at 8:00 pm
While humans evolved over a period of approximately 6 million years, breakthroughs in modern medicine as we know it today got going only in the 19th and 20th centuries. So how did humans successfully ...
- Global Antimicrobial Resistance Diagnostic Market Research 2022: The Changing Road to New Antibiotics & Technologieson July 26, 2022 at 10:05 am
DUBLIN, July 25, 2022 /PRNewswire/ -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization" report has been ...
- CDC calls for increased research into vaccines, therapeutics and diagnostics to tackle antimicrobial resistanceon July 26, 2022 at 7:58 am
The US Centers for Disease Control and Prevention (CDC) says COVID-19 has ‘pushed back years of progress’ in combating antimicrobial resistance (AR) in the US – adding that the threat from AR has also ...
- Antimicrobial Resistance Diagnostic Markets Report, Q3 2022 Edition - Multiple Diagnostic Technologies Create New Global Race - ResearchAndMarkets.comon July 22, 2022 at 3:54 am
The “Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization” report has been added to ResearchAndMarkets.com’s offering.
- Spinach and cabbage can reduce antibiotic resistanceon July 21, 2022 at 6:05 am
A dietician and a nutritionist decode how viruses develop antibiotic resistance and how cruciferous plants are capable of preventing their resistant nature.
via Google News and Bing News